ACCENTMIC2026-04-012026-09-30ACCENTMIC2026-09-30ACCENTMIC2026-03-31ACCENTMIC2026-04-012026-09-30in-capmkt:OtherExpenses1MemberACCENTMIC2026-09-30OtherCurrentLiabilitiesDomain1ACCENTMIC2026-09-30OtherNoncurrentAssetsDomain1ACCENTMIC2026-09-30OtherCurrentAssetsDomain1ACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments1MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments2MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments3MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments4MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments1MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments2MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments3MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments4MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments1MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments1MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments2MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments2MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments3MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments3MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments4MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments4MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments1MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments1MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments2MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments2MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments3MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments3MemberACCENTMIC2026-04-012026-09-30in-capmkt:ReportableSegments4MemberACCENTMIC2026-09-30in-capmkt:ReportableSegments4MemberACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain1ACCENTMIC2026-03-31RelatedPartyTransactionDomain1ACCENTMIC2026-09-30RelatedPartyTransactionDomain1ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain2ACCENTMIC2026-03-31RelatedPartyTransactionDomain2ACCENTMIC2026-09-30RelatedPartyTransactionDomain2ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain3ACCENTMIC2026-03-31RelatedPartyTransactionDomain3ACCENTMIC2026-09-30RelatedPartyTransactionDomain3ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain4ACCENTMIC2026-03-31RelatedPartyTransactionDomain4ACCENTMIC2026-09-30RelatedPartyTransactionDomain4ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain5ACCENTMIC2026-03-31RelatedPartyTransactionDomain5ACCENTMIC2026-09-30RelatedPartyTransactionDomain5ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain6ACCENTMIC2026-03-31RelatedPartyTransactionDomain6ACCENTMIC2026-09-30RelatedPartyTransactionDomain6ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain7ACCENTMIC2026-03-31RelatedPartyTransactionDomain7ACCENTMIC2026-09-30RelatedPartyTransactionDomain7ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain8ACCENTMIC2026-03-31RelatedPartyTransactionDomain8ACCENTMIC2026-09-30RelatedPartyTransactionDomain8ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain9ACCENTMIC2026-03-31RelatedPartyTransactionDomain9ACCENTMIC2026-09-30RelatedPartyTransactionDomain9ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain10ACCENTMIC2026-03-31RelatedPartyTransactionDomain10ACCENTMIC2026-09-30RelatedPartyTransactionDomain10ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain11ACCENTMIC2026-03-31RelatedPartyTransactionDomain11ACCENTMIC2026-09-30RelatedPartyTransactionDomain11ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain12ACCENTMIC2026-03-31RelatedPartyTransactionDomain12ACCENTMIC2026-09-30RelatedPartyTransactionDomain12ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain13ACCENTMIC2026-03-31RelatedPartyTransactionDomain13ACCENTMIC2026-09-30RelatedPartyTransactionDomain13ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain14ACCENTMIC2026-03-31RelatedPartyTransactionDomain14ACCENTMIC2026-09-30RelatedPartyTransactionDomain14ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain15ACCENTMIC2026-03-31RelatedPartyTransactionDomain15ACCENTMIC2026-09-30RelatedPartyTransactionDomain15ACCENTMIC2026-04-012026-09-30RelatedPartyTransactionDomain16ACCENTMIC2026-03-31RelatedPartyTransactionDomain16ACCENTMIC2026-09-30RelatedPartyTransactionDomain16ACCENTMIC2026-09-30Statement1ACCENTMIC2026-04-012026-09-30Statement1ACCENTMIC2026-09-30Statement2ACCENTMIC2026-04-012026-09-30Statement2ACCENTMIC2026-09-30StatementDynamic1I1Statement1ACCENTMIC2026-09-30StatementDynamic1I2Statement1ACCENTMIC2026-09-30StatementDynamic1I3Statement1ACCENTMIC2026-09-30StatementDynamic2I1Statement2ACCENTMIC2026-09-30StatementDynamic2I2Statement2ACCENTMIC2026-09-30StatementDynamic2I3Statement2iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000ACCENTMICNOTLISTEDINE0Q5D01013ACCENT MICROCELL LIMITEDSMEEquity2026-04-012027-03-312026-10-142026-10-09INRLakhsHalf YearlyHalf yearlyGeographical2026-10-1410:00:002026-10-1410:50:00trueCash Flow IndirectNot applicabletruetrueNANAfalsetrue2025-10-14https://accentmicrocell.com/true2true2026-04-012026-09-30UnauditedStandalone174830900025559000177386800089811400030354000-20823000119667000102700024182000307597000136011800041375000004137500000413750000108489000-58990001025900003111600000003111600003111600002398900001012.9712.97011Taking into account no deviation in GCP and negative balance not allowed to be incorporated we have mentioned it as NIL.Majority of the portion of geberal corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company.Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company. Taking into account no deviation in GCP and negative balance not allowed to be incorporated we have mentioned it as NIL.Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company.Taking into account no deviation in this and negative balance not allowed to be incorporated.Other Expenses307597000239890000280212800003042018000008590000027385000282440005348000552620001759890002312510001238710002449600038496600034552280005615180000001346621000250000190838900007201000025379200012645000218202700003536160004521460004748000170842000282335000951400012732010003455228000Other Current Liability123871000Other Non Current Assets12645000Other Current Assets9514000A. Dahej (SEZ Unit)1310829000B. Pirana562080000C Unit-III342000d Inter Unit Sales-99126000177412500001774125000A. Dahej (SEZ Unit)350815000B. Pirana68368000C Unit-III-4406000d Inter Unit Sales04147770001027000102590000311160000A. Dahej (SEZ Unit)877734000B. Pirana764306000C Unit-III1813188000d Inter Unit Sales0345522800003455228000A. Dahej (SEZ Unit)274932000B. Pirana81957000C Unit-III56321000d Inter Unit Sales04132100000413210000308000241820000-370700000-400500047520000021530000-294810004645950001520003408500085610005661000483573000505103000918853000000135645000-40000078280800000782808000000000000613109000000000017880000-2343700000-84569100000-845691000000025780002398900029800000-2686500000-26865000-897480000-89748000944960004748000Accent Microcell Limited******Ashutosh Corporate LLP******One of the directors son and brother is a designated partner in the firmPurchase of fixed assets170000000NA130000-1370000Accent Microcell Limited******Ashutosh Corporate LLP******One of the directors son and brother is a designated partner in the firmPurchase of goods or services170000000NA4400000Accent Microcell Limited******Jainishk Industries******One of the directors son and brother is a partner in the firmPurchase of goods or services170000000NA26710000139640000Accent Microcell Limited******Jainishk Industries******One of the directors son and brother is a partner in the firmSale of goods or services170000000NA11590000244380000Accent Microcell Limited******Claroid Pharmaceuticals Limited******One of the director is common in the company.Sale of goods or services170000000NA3141000140240003684000Accent Microcell Limited******Maccent Biocare Industries******One of the director's brother is a partner in the firmPurchase of goods or services170000000NA188500001520003825000Accent Microcell Limited******Maccent Biocare Industries******One of the director's brother is a partner in the firmSale of goods or services170000000NA0468620000Accent Microcell Limited******Globe Star Valves Private Limited******One of the director is common in the company.Purchase of goods or services170000000NA30100000Accent Microcell Limited******Globe Star Valves Private Limited******One of the director is common in the company.Purchase of fixed assets170000000NA522200022920000Accent Microcell Limited******Aneta Pharmaceuticals Private Limited******One of the director is common in the company.Sale of goods or services170000000NA11990005970001609000Accent Microcell Limited******Accent Biosciences Private Limited******Two common director's in the company.Purchase of goods or services170000000NA24296000-9223000-8335000Accent Microcell Limited******Indo SMC Limited******One of the director is common director in the company.Purchase of fixed assets170000000NA46000-28000-17000Accent Microcell Limited******Globe Star Engineers (India) Pvt Ltd******One of the director's brother is a director in the company.Purchase of fixed assets170000000NA0-590000Accent Microcell Limited******Globe Star Engineers (India) Pvt Ltd******One of the director's brother is a director in the company.Purchase of goods or services170000000NA2670000-25000Accent Microcell Limited******Brohks Healthcare Private Limited******One of the directors son is a Director in the companyPurchase of goods or services170000000NA707000-659260000Accent Microcell Limited******Brohks Healthcare Private Limited******One of the directors son is a Director in the companySale of goods or services170000000NA702000540240002400093205000000Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company.0Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company. Taking into account no deviation in GCP and negative balance not allowed to be incorporated we have mentioned it as NIL.0Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company.Taking into account no deviation in this and negative balance not allowed to be incorporated.Public Issues2023-12-137840000002026-09-30falsefalseGhanshyam Arjanbhai PatelManaging DirectorAhmedabad2026-10-14Rights Issues2025-07-033977130002026-09-30falsefalseTo set up plant for manufacturing Croscarmellose Sodium (CCS), and Sodium Starch Glycolate (SSG) and Caboxymethylcellulose (CMC)NA5439380000724841000180903000Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company.Taking into account no deviation in this and negative balance not allowed to be incorporated.General Corporate PurposesNA17903300001121920000Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company. Taking into account no deviation in GCP and negative balance not allowed to be incorporated we have mentioned it as NIL.Issue Related ExpensesNA610290000657910004762000To Set up plant for manufacturing of Microcrystalline CelluloseNA3232710000627967000304696000Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company.Taking into account no deviation in this and negative balance not allowed to be incorporated.General Corporate PurposesNA694420000106250000Majority of the portion of general corporate purpose utlised for capex purpose and balance capex likely to be met out of internal accruars of the company. Taking into account no deviation in GCP and negative balance not allowed to be incorporated we have mentioned it as NIL.Issue Related ExpensesNA500000005890000890000